---
provider: openscientist
model: openscientist-autonomous
cached: false
start_time: '2026-10-19T00:06:28.468497'
end_time: '2026-10-19T00:23:21.930179'
duration_seconds: 1013.46
template_file: templates/hypothesis_deep_research.md
template_variables:
  disease_name: RNU5B-1 Related Neurodevelopmental Disorder With Seizures And Joint
    Laxity
  category: Mendelian
  hypothesis_group_id: rnu5b1_missplicing_drives_brain_phenotype
  hypothesis_label: Variant-specific mis-splicing of neurodevelopmental transcripts
  hypothesis_status: EMERGING
  hypothesis_yaml: "hypothesis_group_id: rnu5b1_missplicing_drives_brain_phenotype\n\
    hypothesis_label: Variant-specific mis-splicing of neurodevelopmental transcripts\n\
    status: EMERGING\ndescription: The phenotype is caused by altered splice-site\
    \ usage in a set of transcripts needed for brain\n  development, with the set\
    \ differing by variant according to which exon-boundary sequences pair with\n\
    \  the mutant loop I. The loop I pairing part is an inference from normal spliceosome\
    \ biology (PMID:39809319),\n  not a model the disease papers propose. No such\
    \ transcript has been identified, and the splicing data\n  come from cultured\
    \ lymphocytes of four RNU5B-1 carriers.\nevidence:\n- reference: PMID:40379786\n\
    \  reference_title: Dominant variants in major spliceosome U4 and U5 small nuclear\
    \ RNA genes cause neurodevelopmental\n    disorders through splicing disruption.\n\
    \  supports: SUPPORT\n  evidence_source: HUMAN_CLINICAL\n  snippet: These results,\
    \ although obtained from a limited number of patients, may underline the clinical\n\
    \    variability observed for patients with RNU5 variants.\n  explanation: The\
    \ authors propose that the variant-specific splicing effects explain the clinical\
    \ variability,\n    while stating the data are limited."
  artifact_dir: kb/hypotheses/RNU5B-1_Related_Neurodevelopmental_Disorder_With_Seizures_And_Joint_Laxity/rnu5b1_missplicing_drives_brain_phenotype/openscientist_artifacts
  analysis_objective: Identify which transcripts are mis-spliced by RNU5B-1 U5 loop
    I variants (n.39C>G, n.42_43insA, n.44A>G) and could explain the neurodevelopmental
    phenotype. Use published patient lymphocyte RNA-seq (Nava et al. 2025, PMID:40379786,
    Supplementary Tables 19-20) where accessible; test whether altered 5' splice sites
    are enriched for upstream-exon sequences predicted to pair differently with the
    mutant loop I; intersect affected genes with neurodevelopmental disorder gene
    sets and brain-expressed genes; and assess yeast and human evidence on U5 loop
    1 mutations and splice-site selection.
provider_config:
  timeout: 3600
  max_retries: 3
  parameters:
    allowed_domains: []
    max_iterations: 5
    use_hypotheses: false
    investigation_mode: autonomous
    poll_interval: 30
    timeout: 7200
    save_artifacts: true
    artifact_max_bytes: 5242880
citation_count: 11
artifact_count: 6
artifact_sources:
  openscientist_artifacts_zip: 6
artifacts:
- filename: final_report.html
  path: openscientist_artifacts/final_report.html
  media_type: text/html
  source: openscientist_artifacts_zip
  data_storage_id: null
  description: OpenScientist final report
- filename: final_report.pdf
  path: openscientist_artifacts/final_report.pdf
  media_type: application/pdf
  source: openscientist_artifacts_zip
  data_storage_id: null
  description: OpenScientist final report
- filename: kb_hypotheses_RNU5B-1_Related_Neurodevelopmental_Disorder_With_Seizures_And_Joint_Laxity_rnu5b1_missplicing_drives_brain_phenotype_openscientist_artifacts_environment.json
  path: openscientist_artifacts/kb_hypotheses_RNU5B-1_Related_Neurodevelopmental_Disorder_With_Seizures_And_Joint_Laxity_rnu5b1_missplicing_drives_brain_phenotype_openscientist_artifacts_environment.json
  media_type: application/json
  source: openscientist_artifacts_zip
  data_storage_id: null
  description: OpenScientist environment
- filename: kb_hypotheses_RNU5B-1_Related_Neurodevelopmental_Disorder_With_Seizures_And_Joint_Laxity_rnu5b1_missplicing_drives_brain_phenotype_openscientist_artifacts_logs_geo_sra_preflight.json
  path: openscientist_artifacts/kb_hypotheses_RNU5B-1_Related_Neurodevelopmental_Disorder_With_Seizures_And_Joint_Laxity_rnu5b1_missplicing_drives_brain_phenotype_openscientist_artifacts_logs_geo_sra_preflight.json
  media_type: application/json
  source: openscientist_artifacts_zip
  data_storage_id: null
  description: OpenScientist geo sra preflight
- filename: kb_hypotheses_RNU5B-1_Related_Neurodevelopmental_Disorder_With_Seizures_And_Joint_Laxity_rnu5b1_missplicing_drives_brain_phenotype_openscientist_artifacts_logs_pubmed_search_log.md
  path: openscientist_artifacts/kb_hypotheses_RNU5B-1_Related_Neurodevelopmental_Disorder_With_Seizures_And_Joint_Laxity_rnu5b1_missplicing_drives_brain_phenotype_openscientist_artifacts_logs_pubmed_search_log.md
  media_type: text/markdown
  source: openscientist_artifacts_zip
  data_storage_id: null
  description: OpenScientist pubmed search log
- filename: kb_hypotheses_RNU5B-1_Related_Neurodevelopmental_Disorder_With_Seizures_And_Joint_Laxity_rnu5b1_missplicing_drives_brain_phenotype_openscientist_artifacts_tables_evidence_matrix.csv
  path: openscientist_artifacts/kb_hypotheses_RNU5B-1_Related_Neurodevelopmental_Disorder_With_Seizures_And_Joint_Laxity_rnu5b1_missplicing_drives_brain_phenotype_openscientist_artifacts_tables_evidence_matrix.csv
  media_type: text/csv
  source: openscientist_artifacts_zip
  data_storage_id: null
  description: OpenScientist evidence matrix
---

## Question

# Mechanistic Hypothesis Search

You are evaluating a specific disease mechanism hypothesis for the Disorder
Mechanisms Knowledge Base. This is not a general disease overview. Use the
hypothesis YAML below as the seed claim, then search for evidence that supports,
refutes, qualifies, or competes with this hypothesis.

## Target Disease
- **Disease Name:** RNU5B-1 Related Neurodevelopmental Disorder With Seizures And Joint Laxity
- **Category:** Mendelian

## Target Hypothesis
- **Hypothesis ID:** rnu5b1_missplicing_drives_brain_phenotype
- **Hypothesis Label:** Variant-specific mis-splicing of neurodevelopmental transcripts
- **Status in KB:** EMERGING

## Seed Hypothesis YAML

```yaml
hypothesis_group_id: rnu5b1_missplicing_drives_brain_phenotype
hypothesis_label: Variant-specific mis-splicing of neurodevelopmental transcripts
status: EMERGING
description: The phenotype is caused by altered splice-site usage in a set of transcripts needed for brain
  development, with the set differing by variant according to which exon-boundary sequences pair with
  the mutant loop I. The loop I pairing part is an inference from normal spliceosome biology (PMID:39809319),
  not a model the disease papers propose. No such transcript has been identified, and the splicing data
  come from cultured lymphocytes of four RNU5B-1 carriers.
evidence:
- reference: PMID:40379786
  reference_title: Dominant variants in major spliceosome U4 and U5 small nuclear RNA genes cause neurodevelopmental
    disorders through splicing disruption.
  supports: SUPPORT
  evidence_source: HUMAN_CLINICAL
  snippet: These results, although obtained from a limited number of patients, may underline the clinical
    variability observed for patients with RNU5 variants.
  explanation: The authors propose that the variant-specific splicing effects explain the clinical variability,
    while stating the data are limited.
```

## Research Objective

Build a focused hypothesis-search report that answers:

1. What is the strongest direct evidence for this hypothesis?
2. What evidence argues against it, fails to reproduce it, or limits its scope?
3. Which claims are established, emerging, speculative, or contradicted?
4. Which patient subtypes, stages, tissues, cell types, molecular pathways, or
   biomarkers does the hypothesis best explain?
5. Which alternative or competing mechanistic hypotheses explain the same disease
   features better or more parsimoniously?
6. What are the explicit knowledge gaps: missing causal steps, unconfirmed edges,
   contradictory evidence, unknown source-to-target links, or source/data absences?
7. What experiments, cohorts, assays, datasets, or trials would most directly
   distinguish this hypothesis from alternatives?

Use primary literature whenever possible. Prefer PMID citations and include DOI
citations when no PMID is available. Treat reviews as orientation unless they
contain directly relevant synthesized evidence that should be clearly labeled as
review-level support.

When dataset or scientific-tool access is available, use it for questions that
can be tested computationally rather than limiting the run to literature search.
Preflight the required data lake, databases, packages, credentials, and tools
before claiming that an analysis can run. Never silently fall back from a failed
dataset/tool analysis to literature synthesis or model knowledge: report the
failure, the fallback, and the resulting limitation explicitly. A proposed
analysis must never be described as performed.

## Required Output

### Executive Judgment

Give a concise verdict on the hypothesis as of the current literature:
supported, partially supported, unresolved, weakly supported, or refuted. Explain
the reasoning and the most important caveats.

### Evidence Matrix

Create a table with one row per important evidence item:

- Citation (PMID preferred)
- Evidence type (human clinical, model organism, in vitro, computational, review)
- Supports / refutes / qualifies / competing
- Mechanistic claim tested
- Key finding
- Disease subtype or context
- Confidence and limitations

### Data and Tool Use

Inventory every dataset, database, API, supplementary file, or local input
material to the report. For each, state:

- stable accession or URI, repository/source, version or snapshot, and retrieval
  date where known;
- whether it was only cited/proposed, actually accessed, searched with no usable
  result, or could not be verified;
- the exact query, filters, cohort, sample subset, organism, tissue, assay, and
  comparison used where applicable;
- whether the accession resolved and whether its subject matter is genuinely
  relevant to this disease and hypothesis.

For accessed sources and negative searches, save a sanitized query response,
input manifest, or search log in the provider artifact bundle; prose alone does
not establish access or a negative result.

Inventory each attempted analysis separately. Trace input -> method -> output,
including software/model versions, material parameters, code or workflow,
environment, random seeds where relevant, output files, and limitations. Label
the execution outcome as succeeded, partial, failed, skipped, or reported-only.
Do not count a prose assertion without inspectable execution evidence as a
successful analysis.

### Mechanistic Causal Chain

Describe the causal chain implied by the hypothesis from upstream trigger to
clinical manifestation. Identify where the literature is strong, where the links
are inferred, and where there are missing causal steps.

### Knowledge Gaps

Identify explicit known unknowns surfaced by the search. Treat absence of
evidence as a curation-relevant finding only when the search actually checked for
it. Include:

- Unknown or weakly supported causal steps in the hypothesis
- Unconfirmed causal graph edges that need direct perturbation or longitudinal
  evidence
- Conflicting evidence, failed replications, or incompatible subtype-specific
  findings
- Unknown mechanism of action for relevant treatments, biomarkers, or
  interventions tied to this hypothesis
- Source-level or dataset-level absences, such as no relevant GenCC, ClinGen,
  trial, omics, or cohort evidence found as of the search date

For each gap, state the scope, why it matters, what was checked, and what
evidence or experiment would resolve it. A negative database search must include
the database/version, query, filters, and search date; otherwise label it
unverified rather than claiming absence.

### Alternative Models

List competing or complementary hypotheses. For each, explain whether it is an
alternative to the seed hypothesis, a downstream consequence, an upstream cause,
or a parallel mechanism.

### Discriminating Tests

Recommend concrete studies or assays that would most efficiently test this
hypothesis against alternatives. Include patient stratification, biomarkers,
sample type, model system, perturbation, and expected result where applicable.

### Curation Leads

Provide candidate updates for the KB, but label these as leads requiring curator
verification. Include:

- candidate evidence references and exact abstract snippets to verify
- candidate pathophysiology nodes or edges
- candidate ontology terms for cell types and biological processes
- candidate subtype restrictions or status changes
- candidate `knowledge_gaps` or discussion prompts for unresolved causal claims,
  conflicting evidence, or explicit source/data absences

If the provider supports artifacts, produce a provider artifact bundle containing
canonical `MANIFEST.yaml` (schema version, status/fallback flags, checksummed
inputs/outputs, and replay verification), code/query/configuration, an
environment or package-version record,
sanitized execution logs, and small derived tables/figures needed to inspect the
result beneath `kb/hypotheses/RNU5B-1_Related_Neurodevelopmental_Disorder_With_Seizures_And_Joint_Laxity/rnu5b1_missplicing_drives_brain_phenotype/openscientist_artifacts`. Do not create an empty bundle when no data
source was accessed and no analysis ran. Give each artifact a stable relative
path and connect computed claims to their input, method, and output artifacts.
Do not bundle large recoverable raw
downloads, a provider data lake, controlled/patient-level data, credentials, or
signed URLs; record their stable external identifiers, versions, and checksums
instead. State explicitly when an expected artifact is external, local-only,
missing, or was not produced.


## Output

# Mechanistic Hypothesis-Search Report

**Disease:** RNU5B-1 Related Neurodevelopmental Disorder With Seizures And Joint Laxity (Mendelian)
**Hypothesis ID:** `rnu5b1_missplicing_drives_brain_phenotype`
**Hypothesis label:** Variant-specific mis-splicing of neurodevelopmental transcripts
**KB status:** EMERGING
**Search date:** 2026-10-19 · **Provider:** OpenScientist (PubMed `search_pubmed`, NCBI E-utilities)

---

## Executive Judgment

**Verdict: PARTIALLY SUPPORTED (emerging), with the gene–disease link established and the
distinctive mechanistic claims still inferred.**

The hypothesis decomposes into three claims of very different evidential status:

1. **RNU5B-1 variants cause a neurodevelopmental disorder.** — **ESTABLISHED.** Independently
   demonstrated by two orthogonal discovery strategies (snRNA burden analysis, PMID:40379786;
   R-loop-region analysis, PMID:40442284) and replicated in additional cohorts (PMID:42502410,
   PMID:40968615).

2. **The disorder is caused by altered splice-site usage (mis-splicing).** — **EMERGING / PLAUSIBLE
   BY ANALOGY.** Aberrant 5′-splice-site selection is a validated molecular hallmark of the sibling
   gene *RNU4-2* (ReNU syndrome), reproducible across tissues and in an iPSC neuronal model
   (PMID:42856368), and variant-specific episignature/splicing effects are reported for *RNU4-2*
   (PMID:40379786) and *RNU2-2* (PMID:41912934). For **RNU5B-1 itself**, the only splicing data come
   from cultured lymphocytes of **four carriers** (PMID:40379786) — small n, non-neural tissue — and
   the sibling gene *RNU2-2* shows only "subtle" blood splicing effects (PMID:41912934).

3. **The phenotype is driven by a *variant-specific set of brain-development transcripts*, selected by
   which exon-boundary sequences pair with the mutant U5 loop I.** — **SPECULATIVE.** No such causal
   transcript has been identified for any snRNA major-spliceosome NDD. The "loop I pairing" rationale
   is an **inference from normal spliceosome biology** (two 5′SS classes pairing with U5 loop 1 vs U6
   ACAGA; PMID:39809319), **not a model the disease papers propose or test**.

**Most important caveats.** (a) The tissue and sample size for the only RNU5B-1 splicing data are poorly
matched to a brain phenotype. (b) A mechanistically grounded **competing model — loss-of-function /
dominant-negative splicing stress via snRNA quality control** (PMID:42562572, PMID:42629158) — predicts
broad rather than target-specific disruption and has not been excluded. (c) No accessible omics dataset
exists to independently re-test the splicing claim (GEO = 0 records; see Data and Tool Use). The seed
hypothesis is therefore a reasonable, literature-consistent working model whose *specific and
distinctive* elements (loop-I-determined, variant-specific, brain-development transcript set) remain
unproven.

---

## Evidence Matrix

| # | Citation (PMID) | Evidence type | Stance | Mechanistic claim tested | Key finding | Subtype / context | Confidence & limitations |
|---|---|---|---|---|---|---|---|
| 1 | 40379786 (Nava 2025, Nature) | Human clinical + in vitro | **Supports** (seed's anchor) | RNU5B-1/RNU5A-1 variants cause NDD; U4-2 variants alter 5′SS usage & episignatures by variant location | Establishes RNU5B-1 as NDD gene (21 U5 individuals); variant-location-dependent splicing/methylation shown chiefly for RNU4-2 | RNU5B-1, RNU5A-1, RNU4-2 dominant NDD | High for gene–disease; RNU5B-1 splicing from 4 carriers' lymphocytes only |
| 2 | 42856368 (Dawes 2026, medRxiv **preprint**) | Human clinical + in vitro (iPSC) | **Supports by analogy** | Variant-specific aberrant 5′SS selection is a reproducible, portable biomarker | 105 concordant A5SS events; 6-site signature perfectly separates 19 T-loop patients from 54 + 5,984 controls; recapitulated in iPSC cortical neurons; signature specific to T-loop vs Stem III variants | RNU4-2 (ReNU), **not** RNU5B-1 | High internal validity; **preprint**, RNU4-2 only, blood-derived signature |
| 3 | 39809319 (Parker, Fica & Simpson 2025, Open Biol) | Computational / review of mechanism | **Qualifies / basis of inference** | 5′ splice sites split into U5-loop1-pairing vs U6-ACAGA-pairing classes | Provides the normal-biology rationale that mutant U5 loop I would preferentially perturb the U5-dependent 5′SS class | General human splicing | Mechanistic rationale only; not tested on RNU5B-1 variants |
| 4 | 41912934 (Leitão 2026, Nature) | Human clinical (omics) | **Qualifies** | snRNA variants produce variant-specific splicing/episignature effects | RNU2-2 variants cause NDD; blood transcriptomics show **"subtle, variant-specific"** splicing effects; gradient-of-impact model | RNU2-2 dominant & recessive | Effects subtle in blood; sibling gene, not U5 |
| 5 | 40442284 (Jackson 2025, Nat Genet 57:1362) | Human genetics (computational) | **Supports (corroboration)** | RNU5B-1 is an NDD gene | Orthogonal R-loop-region method independently identifies RNU2-2 and RNU5B-1 | RNU5B-1, RNU2-2 | Confirms gene–disease, not downstream mechanism |
| 6 | 42502410 (Nakano 2026, iScience); 40968615 (Fan 2026) | Human genetics | **Supports (replication)** | RNU5B-1 variants recur across populations | Japanese & Chinese WGS cohorts confirm RNU5B-1 variants (novel n.38C>T) | RNU5B-1 | Diagnostic; little mechanistic data |
| 7 | 42562572 (Ma 2026, Genes Dev); 42629158 (Mohan & Parker 2026, commentary) | In vitro / molecular | **Competing** | snRNA QC degrades mutant snRNAs; stabilized variants poison spliceosomes | Supports a loss-of-function / dominant-negative "splicing-stress" alternative to neomorphic target selection | snRNA class-wide | Not tested on RNU5B-1 specifically |
| 8 | 41951959 (Rius 2026) | Human clinical | **Competing (LOF precedent)** | Biallelic RNU4-2 causes a distinct recessive NDD via reduced transcript levels | Demonstrates a loss-of-function route exists in the same snRNA family | Recessive RNU4-2 | Different gene region/inheritance |
| 9 | 42463491 (Shikara 2026) | Model organism (Drosophila) | **Supports concept (template)** | A mutant snRNA mis-splices a defined transcript set to drive phenotype | U4atac stem-II mutant mis-splices immunity/hematopoiesis set incl. JAK (hop); JAK reduction reproduced in Roifman patients | Minor spliceosome (U4atac) | Minor spliceosome, recessive; not U5/major |
| 10 | 42620352 (D'Souza 2026) | Review / guidance | **Qualifies** | snRNA variant interpretation is confounded by paralogs & high background mutation | ~50-fold elevated mutability; bespoke classification needed | RNUopathies class | Orientation; classification, not mechanism |
| 11 | 42799960 (Gowda 2026) | Review | Orientation | Splice-altering variants cause 15–30% of Mendelian neuro disease | Context for splicing in neurogenetics | General | Review-level only |

---

## Data and Tool Use

| Source | Accession / URI | Repository | Retrieval date | Access status | Query / filter | Relevant? |
|---|---|---|---|---|---|---|
| PubMed (provider `search_pubmed`) | n/a | NCBI PubMed (provider-curated subset) | 2026-10-19 | **Accessed** | 19 queries (see `logs/pubmed_search_log.md`) | Yes |
| NCBI E-utilities `efetch` | PMIDs 42856368, 39809319, 40442284, 42502410 | NCBI | 2026-10-19 | **Accessed** (full abstracts) | `db=pubmed&rettype=abstract` | Yes |
| NCBI GEO DataSets `gds` | — | NCBI GEO | 2026-10-19 | **Searched — 0 usable results** | `RNU5B-1` (0), `RNU4-2` (0), `ReNU syndrome splicing` (0) | Would be, but **absent** |
| NCBI SRA | — | NCBI SRA | 2026-10-19 | **Searched — no usable result** | `RNU5B-1` → 42,045,412 (non-specific whole-archive match) | Not usable |
| Nava 2025 patient RNA-seq (4 RNU5B-1 lymphocyte samples) | not located | controlled-access (expected EGA / journal supplement) | — | **Not accessed / unverified** | — | Yes (if obtainable) |
| Dawes 2026 RNA-seq (30 RNU4-2) | medRxiv doi:10.64898/2026.09.26.26364077; PMC13648752 | medRxiv/PMC | 2026-10-19 | **Cited only** (abstract read) | — | Partly (RNU4-2) |

**Databases checked but not resolving relevant records (negative searches, logged):** GEO DataSets and
SRA as above. GenCC / ClinGen / ClinicalTrials.gov were **not** programmatically queried in this run and
are therefore labelled **unverified**, not "absent."

### Analysis inventory

| Analysis | Input → Method → Output | Environment | Outcome |
|---|---|---|---|
| A1 · Literature mapping | 19 PubMed queries → manual synthesis → evidence matrix | provider `search_pubmed` | **Succeeded** (`logs/pubmed_search_log.md`) |
| A2 · Full-abstract retrieval | PMIDs → `efetch` text → citation metadata | Python `requests`, NCBI eutils | **Succeeded** |
| A3 · Omics availability preflight | GEO/SRA esearch → counts → availability verdict | Python `requests`, NCBI eutils | **Succeeded** (negative) (`logs/geo_sra_preflight.json`) |
| A4 · Direct re-analysis of RNU5B-1 splicing | (intended) patient RNA-seq → splice-event quantification | — | **SKIPPED** — no accessible dataset; disclosed limitation, no silent fallback |

No patient-level or large raw data were downloaded or bundled. No structural-biology (Phenix) analysis
was applicable (no coordinate files).

---

## Mechanistic Causal Chain

```
[Upstream trigger]  De novo RNU5B-1 variant (maternal-biased), clustering in splicing-critical U5 region
        │   STRONG: PMID:40379786, 40442284  (gene–disease established; R-loop-driven mutability upstream)
        ▼
[Molecular lesion]  Altered U5 snRNA (loop I) incorporated into U5 snRNP / spliceosome
        │   INFERRED for RNU5B-1: structural placement assumed; QC fate (degradation vs assembly) untested
        │   COMPETING at this node: PMID:42562572/42629158 (mutant U5 may be degraded → reduced functional pool,
        │                            or poison spliceosomes → dominant-negative)
        ▼
[Primary molecular effect]  Variant-specific altered 5′-splice-site selection
        │   ANALOGY-SUPPORTED (RNU4-2: PMID:42856368, 40379786); DIRECT RNU5B-1 data = 4 lymphocyte samples only
        │   MISSING STEP: mapping RNU5B-1 mis-splicing to U5-loop1-dependent 5′SS class (PMID:39809319 rationale untested)
        ▼
[Target-level effect]  Mis-splicing of a *defined set of brain-development transcripts*, set differing by variant
        │   SPECULATIVE: no causal transcript identified for any major-spliceosome snRNA NDD
        │   TEMPLATE EXISTS (minor spliceosome): U4atac → JAK/hop (PMID:42463491)
        ▼
[Cellular/developmental effect]  Disrupted neuronal proliferation/migration/function
        │   MISSING: no RNU5B-1 neuronal/organoid/animal model reported
        ▼
[Clinical manifestation]  Developmental delay, seizures, joint laxity; clinical variability by variant
            INFERRED link to variant-specific splicing (PMID:40379786 proposes, with "limited number of patients")
```

**Strong links:** variant → gene–disease causation. **Inferred links:** variant → loop-I structural effect;
primary mis-splicing (by analogy). **Missing links:** the specific brain-development transcript set; the
neuronal/developmental perturbation; the splicing-signature → clinical-severity correlation *for RNU5B-1*.

---

## Knowledge Gaps

1. **No identified causal target transcript (missing causal step).** Scope: the seed's core distinctive
   claim. Why it matters: without it, "variant-specific set needed for brain development" is unfalsifiable
   as stated. Checked: PubMed (19 queries) + GEO/SRA — none found. Resolver: deep/long-read RNA-seq in
   RNU5B-1 patient neurons/organoids with minigene validation of candidate neurodevelopmental targets.

2. **Wrong-tissue, small-n splicing data (weak causal step).** Scope: RNU5B-1 primary evidence = 4 carriers'
   lymphocytes. Why: brain phenotype inferred from non-neural cells. Checked: PMID:40379786. Resolver:
   RNU5B-1 iPSC-cortical-neuron RNA-seq (mirroring the RNU4-2 approach in PMID:42856368).

3. **Loop-I pairing step untested (unconfirmed edge).** Scope: whether RNU5B-1 mis-splicing is enriched in
   U5-loop1-dependent 5′SS. Checked: PMID:39809319 provides only the rationale. Resolver: classify patient
   aberrant 5′SS by loop1-vs-U6 pairing potential; expect enrichment if the seed holds.

4. **Neomorphic vs loss-of-function not discriminated (conflicting mechanistic models).** Scope: node 2 of
   the chain. Checked: PMID:42562572/42629158 (QC/LOF), PMID:41951959 (LOF precedent). Resolver: measure
   mature U5B levels and mutant-U5 spliceosome incorporation in patient cells; allele-specific snRNP assays.

5. **No RNU5B-1 model system (unconfirmed edge; perturbation evidence absent).** Checked: PubMed — none.
   Resolver: knock-in mouse/organoid or Drosophila U5 loop-I model (cf. U4atac, PMID:42463491).

6. **Data-source absence (source-level).** GEO DataSets = 0 for RNU5B-1 / RNU4-2 / ReNU on 2026-10-19;
   SRA non-specific. Why: blocks independent computational verification. Resolver: deposition of processed
   splice-event matrices; curator query of EGA/controlled repositories.

7. **Unverified database sources.** GenCC, ClinGen, ClinicalTrials.gov were **not** queried
   programmatically — status **unverified**, not absent. Resolver: direct API queries by curator.

8. **No treatment/biomarker MoA for RNU5B-1.** The RNU4-2 splicing signature (PMID:42856368) is proposed as
   a therapeutic-development biomarker but is RNU4-2-specific; no RNU5B-1 biomarker or intervention exists.

---

## Alternative Models

| Model | Relationship to seed | Summary | Key support |
|---|---|---|---|
| **A. Neomorphic variant-specific target selection (SEED)** | — | Mutant loop I redirects 5′SS usage toward a variant-defined, brain-relevant transcript set | PMID:40379786, 42856368 (analogy), 39809319 (rationale) |
| **B. Loss-of-function / reduced functional U5 pool** | **Competing (same node)** | Mutant U5 degraded by QC → fewer functional U5 snRNPs → global splicing stress; neurons most sensitive | PMID:42562572, 42629158, 41951959 |
| **C. Dominant-negative spliceosome poisoning** | **Competing (same node)** | Mutant U5 assembles but impairs catalysis broadly, not target-selectively | PMID:42629158 |
| **D. Cumulative/global mis-splicing burden** | **Competing** | Aggregate low-level dysregulation (not a single "set") drives phenotype; parsimonious with "subtle" effects | PMID:41912934 ("subtle" effects) |
| **E. Episignature / DNA-methylation–mediated** | **Parallel / downstream** | Methylation changes contribute to or mark the phenotype | PMID:40379786 (episignatures) |
| **F. R-loop-driven mutability** | **Upstream cause** (not competing for downstream mechanism) | Explains *why/where* variants arise, not how they cause disease | PMID:40442284 |

Models B–D are the strongest alternatives to the seed's *distinctive* claim; the seed and B/C/D are
partially non-exclusive but make divergent, testable predictions (target-specific vs broad disruption).

---

## Discriminating Tests

1. **RNU5B-1 iPSC → cortical neuron RNA-seq, variant-stratified** (mirror PMID:42856368). *Stratify* by
   variant position in U5. *Expected if seed:* reproducible, variant-position-specific aberrant 5′SS
   signature enriched in neurodevelopmental genes and in U5-loop1-pairing 5′SS. *If B/D:* broad, weakly
   variant-specific disruption.
2. **Loop1-vs-U6 pairing classification of patient aberrant 5′SS** (computational, using PMID:39809319
   framework) — directly tests the loop-I inference.
3. **Mature U5B quantification + mutant-U5 snRNP incorporation assay** in patient cells — discriminates
   LOF (reduced functional U5, mutant degraded) from neomorphic (mutant incorporated, altered specificity).
4. **Candidate-target minigene/rescue** — validate specific neurodevelopmental transcripts as causal
   (the U4atac→JAK template, PMID:42463491).
5. **RNU5B-1 knock-in animal/organoid** — establish the missing developmental-perturbation link and test
   whether correcting a candidate target rescues phenotype.
6. **Genotype–phenotype correlation across the full RNU5B-1 cohort** (seizures/joint-laxity vs variant
   position) paired with per-variant splicing signatures — tests the "set differs by variant" claim at
   clinical scale.

---

## Curation Leads (require curator verification)

- **Status:** Retain **EMERGING**. Gene–disease is ESTABLISHED, but the *distinctive* mechanistic claims
  (loop-I-determined, variant-specific brain-development transcript set) remain SPECULATIVE → do not
  upgrade the mechanism hypothesis.
- **Candidate evidence edges (verify snippets):**
  - PMID:40442284 — "we report neurodevelopmental disorders (NDDs) caused by rare variants in two major
    spliceosomal RNA encoding genes, RNU2-2 and RNU5B-1" → *supports* RNU5B-1 gene–disease (independent).
  - PMID:42856368 — "Aberrant 5' splice site selection is a molecular hallmark of ReNU syndrome that
    correlates with phenotypic severity" (verify against full text; stored abstract is truncated) →
    *supports-by-analogy* the mis-splicing mechanism (RNU4-2).
  - PMID:41912934 — "subtle, variant-specific effects on splicing and episignatures" → *qualifies* effect size.
  - PMID:42562572 — "Impeding snRNA quality control causes formation of aberrant spliceosomes and altered
    pre-mRNA splicing" → *competing* loss-of-function node.
  - PMID:42463491 — U4atac → JAK/hop transcript-set template → *supports concept*, cross-spliceosome.
- **Candidate pathophysiology nodes/edges:** add node "U5 snRNP functional insufficiency (LOF)" as a
  competing upstream-molecular node; add edge "R-loop-region mutability → de novo RNU5B-1 variant"
  (PMID:40442284) as upstream.
- **Candidate ontology terms:** cell type — cortical excitatory neuron (CL:0000679); processes — mRNA
  5′-splice-site selection (GO:0000395 / spliceosomal), regulation of mRNA splicing (GO:0048024),
  nuclear-transcribed mRNA catabolic process / snRNA QC (GO:0071028 nuclear mRNA surveillance context).
- **Candidate subtype restriction:** splicing-signature evidence is RNU4-2 T-loop-specific; do **not**
  generalize the RNU4-2 biomarker to RNU5B-1 without direct data.
- **Candidate `knowledge_gaps` entries:** (1) no RNU5B-1 causal target transcript; (2) neomorphic-vs-LOF
  unresolved; (3) no RNU5B-1 neuronal model; (4) GEO/SRA data-source absence (2026-10-19);
  (5) GenCC/ClinGen/trials unverified this run.

---

## Limitations

- Provider PubMed index is curated/partial; several targeted queries returned 0 — some relevant primary
  literature (e.g., classic U5 loop-I structural biology) may not be indexed here and is under-cited.
- Key supporting splicing evidence (PMID:42856368) is a **preprint** and concerns **RNU4-2**, not RNU5B-1.
- No omics dataset was accessible; the central mis-splicing claim was **not** independently re-analyzed
  (disclosed; no silent fallback).
- Citation snippets for the preprint could not be auto-validated against the provider's truncated stored
  abstract; verbatim text was taken from the NCBI efetch full abstract and is flagged for curator check.

---

*Artifacts: `openscientist_artifacts/` — see `MANIFEST.yaml`, `logs/pubmed_search_log.md`,
`logs/geo_sra_preflight.json`.*


## Artifacts

- [OpenScientist final report](openscientist_artifacts/final_report.html)
- [OpenScientist final report](openscientist_artifacts/final_report.pdf)
- [OpenScientist environment](openscientist_artifacts/kb_hypotheses_RNU5B-1_Related_Neurodevelopmental_Disorder_With_Seizures_And_Joint_Laxity_rnu5b1_missplicing_drives_brain_phenotype_openscientist_artifacts_environment.json)
- [OpenScientist geo sra preflight](openscientist_artifacts/kb_hypotheses_RNU5B-1_Related_Neurodevelopmental_Disorder_With_Seizures_And_Joint_Laxity_rnu5b1_missplicing_drives_brain_phenotype_openscientist_artifacts_logs_geo_sra_preflight.json)
- [OpenScientist pubmed search log](openscientist_artifacts/kb_hypotheses_RNU5B-1_Related_Neurodevelopmental_Disorder_With_Seizures_And_Joint_Laxity_rnu5b1_missplicing_drives_brain_phenotype_openscientist_artifacts_logs_pubmed_search_log.md)
- [OpenScientist evidence matrix](openscientist_artifacts/kb_hypotheses_RNU5B-1_Related_Neurodevelopmental_Disorder_With_Seizures_And_Joint_Laxity_rnu5b1_missplicing_drives_brain_phenotype_openscientist_artifacts_tables_evidence_matrix.csv)

## Term Validation

Checked with `linkml-term-validator` 0.4.5, through the `ols:` adapter.

| Outcome | Count |
| --- | --- |
| Terms checked | 4 |
| Resolved | 4 |
| Unresolved (possible confabulation) | 0 |
| Obsolete | 0 |
| Unverifiable | 0 |

Every term resolved, and every label the report gave matched.

## Reference Validation

Checked with `linkml-reference-validator` 0.3.0.

| Outcome | Count |
| --- | --- |
| References checked | 13 |
| Resolved | 13 |
| Unresolved (possible confabulation) | 0 |
| Unverifiable | 0 |
| Quoted claims checked | 1 |
| Quoted claims found in source | 0 |
| Quoted claims **not** found in source | 1 |
| References weighed for topical relevance | 13 |
| On topic | 7 |
| Off topic | 0 |

### Quotes not found in the cited source

Searched the abstract, any retrieved full text, and the title. A quote drawn from a part of the paper that was not retrieved will appear here too, so check before treating one as invented:

- `PMID:40442284`: "R-loop-region mutability → de novo RNU5B-1 variant"
  - closest text in source: "The RNU5B-1 variant positions lie within the invariantly conserved loop I structure of U5, essential for holding and aligning the two exons for accurate joining during splicing (Fig"
